Myomo (MYO) director buys 7,437 shares at $0.72 on open market
Myomo, Inc. (MYO) reported insider share purchases by a director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Myomo, Inc. (MYO) reported insider share purchases by a director. On 11/20/2025, the director bought 4,902 shares of common stock in the open market at $0.72 per share, and on 11/21/2025 bought an additional 2,535 shares at $0.72 per share. After these transactions, the director beneficially owned 481,857 shares of Myomo common stock in direct ownership. The purchases were disclosed on a Form 4 filed for a single reporting person.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 2,535 | $0.72 | $2K |
| Purchase | Common Stock | 4,902 | $0.72 | $4K |
Footnotes (2)
- F1. Represents open market purchases.
- F2. Shares were purchased in multiple lots, each executing at $0.72 per share. Reporting Party agrees to provide details of the transactions to the SEC upon request.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Myomo (MYO) disclose on this Form 4?
Were these Myomo (MYO) trades open market purchases?
Is this Myomo (MYO) Form 4 filed for more than one reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.